Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
This month's Broker Brief breaks down: - Why up to 65% of GLP-1 users discontinue within a year, and why that turns coverage into a sunk cost for employers - What oral GLP-1s like Lilly's Foundayo mean for demand, when most plans still have eligibility rules written for injectables only - How fast a PBM formulary decision can move, using this year's Zepbound to Wegovy switch and back as the case in point - Why 38% of employers already tie GLP-1 coverage to participation in a lifestyle or behavioral program If you're advising employers on GLP-1 coverage, this is where the conversation is heading
Regular collagen intake is linked with improved skin hydration and firmness
In addition, multiple food intolerances commonly develop as the situation goes untreated
It is not for human or veterinary use
US$ 20.87
US$ 28.22
US$ 21.97
